These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. DOCTOR MEDICATION GUESSES: AN INDICATOR OF CLINICAL IMPROVEMENT IN DOUBLE-BLIND STUDIES. A CONTRIBUTION TO THE METHODOLOGY OF PSYCHIATRIC DRUG EVALUATION. RICKELS K, CARRANZA J, RAAB E. J New Drugs; 1965 Jun; 5(2):67-71. PubMed ID: 14315152 [No Abstract] [Full Text] [Related]
5. LONG-TERM THERAPY WITH NEUROTROPIC DRUGS IN PSYCHIATRIC OUTPATIENTS. MCLAUGHLIN BE. GP; 1964 Jul; 30():99-105. PubMed ID: 14155219 [No Abstract] [Full Text] [Related]
6. CONTROLLED PSYCHOPHARMACOLOGICAL RESEARCH IN GENERAL PRACTICE. RICKELS K, BOREN R, STUART HM. J New Drugs; 1964 Jul; 4(3):138-47. PubMed ID: 14191407 [No Abstract] [Full Text] [Related]
10. CHLORPROTHIXENE: A NEW NON-PHENOTHIAZINE ATARACTIC AGENT: SPECTRUM IN THE OUTPATIENT THERAPY OF PSYCHONEUROSIS. LEVY HA, BODI T, SIEGLER PE, SLAP J, NODINE JH. J Neuropsychiatr; 1963 Dec; 4():138-42. PubMed ID: 14112292 [No Abstract] [Full Text] [Related]
11. A DOUBLE-BLIND EVALUATION OF TYBAMATE IN ANXIOUS NEUROTIC MEDICAL CLINIC PATIENTS. RAAB E, RICKELS K, MOORE E. Am J Psychiatry; 1964 Apr; 120():1005-7. PubMed ID: 14138831 [No Abstract] [Full Text] [Related]
12. DOUBLE BLIND STUDY WITH DIAZEPAM, CHLORDIAZEPOXIDE AND PLACEBO IN THE TREATMENT OF PSYCHONEUROTIC ANXIETY. DANEMAN EA. J Med Assoc Ga; 1964 Feb; 53():55-8. PubMed ID: 14256274 [No Abstract] [Full Text] [Related]
14. A CLINICAL EVALUATION OF HYDROXYZINE AND PLACEBO IN ANXIOUS PSYCHIATRIC OUTPATIENTS. MOCK JE, RICKELS K, YEE R. Int J Neuropsychiatry; 1965 Feb; 1():168-72. PubMed ID: 14309076 [No Abstract] [Full Text] [Related]
15. A TWO-PART, DOUBLE-BLIND STUDY OF THE ANTI-NEUROTIC ACTION OF TYBAMATE. CHIEFFI M. Dis Nerv Syst; 1965 Jun; 26():369-74. PubMed ID: 14315073 [No Abstract] [Full Text] [Related]
16. THE ROLE OF TRANQUILIZERS IN MEDICAL PRACTICE IN THE CONTROL OF ANXIETY. THE GENERAL PRACTITIONER'S ROLE IN THE CONTROL OF ANXIOUS AND NEUROTIC PATIENTS. MICHAELSON J. J Neuropsychiatr; 1964 Oct; 5():440-1. PubMed ID: 14249414 [No Abstract] [Full Text] [Related]
17. A CONTROLLED STUDY OF 4-(1-PHENYL-4-PIPERAZINYL)-BUTYL 3,4,5-TRIMETHOXYBENZATE HYDROCHLORIDE (MA 568) AND MEPROBAMATE IN PSYCHIATRIC OUTPATIENTS. JANECEK J, SCHIELE BC, BELLVILLE TP, VESTRE ND. J New Drugs; 1965 Oct; 5(1):51-6. PubMed ID: 14283068 [No Abstract] [Full Text] [Related]
18. A LONG RELEASE DOSE FORM OF PENTOBARBITAL COMPARED WITH MEPROBAMATE IN THE MANAGEMENT OF ANXIETY STATES. ABRUZZI WA. Clin Med (Northfield); 1964 Jul; 71():1231-4. PubMed ID: 15446194 [No Abstract] [Full Text] [Related]
19. PANEL DISCUSSION. 3. THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. ASSAY OF ANTI-ANXIETY DRUGS BY QUANTITATIVE ELECTROENCEPHALOGRAPHY. PFEIFFER CC, GOLDSTEIN L. J Neuropsychiatr; 1964 Oct; 5():475-86. PubMed ID: 14249422 [No Abstract] [Full Text] [Related]
20. Evaluating clinical improvement in anxious outpatients: a comparison of normal and treated neurotic patients. Rickels K, Lipman RS, Garcia CR, Fisher E. Am J Psychiatry; 1972 Feb; 128(8):1005-9. PubMed ID: 4550730 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]